Private equity firm LBO France has invested in FeetMe, a medical device company that produces smart medical wearables and digital health services to improve mobility. The investment will be used to accelerate FeetMe’s commercial activities through clinical trials. FeetMe's technology uses pressure sensors, motion sensors and learning algorithms to analyse patients’ functional capacity and help rehabilitation among sufferers of gait disorders. Alexis Mathieu, Founder and CEO of FeetMe, said: “Our platform has demonstrated it can generate unique insights and real-world evidence to accelerate clinical research at scale, and our Feetme Evaluation solution is setting a new standard for long-term continuous mobility assessment of patients with gait disorders.” Philippe Chambon, Venture Partner at LBO France, added: “With its disruptive yet technically validated technology, FeetMe establishes itself as the global leader in long-term continuous mobility assessment, with the potential to improve diagnosis for the millions of patients each year who present with known and unknown walking difficulties. I believe that FeetMe, with its vast technology capabilities, has the ability to create the world's largest and highest quality gait pattern data set to create a variety of new digital biomarkers across disease areas.”
